Zurueck zur Suche

Reporte zur Charge UJ443AB

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MA 1

VAERS 1848618

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ443AB

gering
Staat
-
Alter
76,0
Geschlecht
F
Eingang
06.11.2021
Impfdatum
26.10.2021
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired dose of FLUZONE HIGH DOSE QUADRIVALENT was administered with no reported adverse event; Initial information received on 26-Oct-2021 regarding an unsolicited valid non-serious case from a other healthcare professional and consumer or other nonprofessional via Global Media information (under the reference 00829446). This case involves a 76-year-old female patient receiving expired dose of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (expired product administered). The patient medical history, medical treatment(s), vaccination(s) and family history were not provided. On 26-Oct-2021, the patient received a0.7 mL total dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [oral solution, Frequency: once, Dose: 0.7 mL, Strength: Fluzone HD, lot UJ443AB, expiry date: 30-Jun-2021] via intramuscular route in the left arm for prophylactic vaccination. It was a case of actual medication error due to expired vaccine use (latency same day) The reporter reported " Caller clinical nurse manager reports administering expired FLUZONE HIGH DOSE QUADRIVALENT to two patients." At the time of report, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out by the regulatory authority. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1839374

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ443AB

gering
Staat
MA
Alter
75,0
Geschlecht
M
Eingang
03.11.2021
Impfdatum
26.10.2021
Beginn
26.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

administering expired FLUZONE HIGH DOSE QUADRIVALENT to two patients with no reported adverse event; Initial information was received on 26-Oct-2021 regarding an unsolicited valid non-serious case received from other healthcare professional and non-healthcare professional via (Global Medical Information-00829494) in a specific country. This case involves a 75-years old male patient who was vaccinated with expired dose of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (Expired product administered). The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. No other concomitant vaccines were not provided. On 26-Oct-2021, the patient received a 0.7ml {total} dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (Oral solution, lot number UJ443AB and expiry date 30-Jun-2021) via intramuscular route at an unknown administration site for prophylactic vaccination. It was a case of an actual medication error due to expired vaccine used (latency was on same day). At the time of report, no adverse event reported. Event outcome was unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-